Detalhe da pesquisa
1.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Cancer
; 128(5): 966-974, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784056
2.
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose-expansion cohort.
Am J Hematol
; 96(4): 428-435, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421178
3.
A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas.
Oncologist
; 22(10): 1152-e98, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28765502
4.
A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia.
Oncologist
; 22(10): 1156-e111, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687625
5.
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Breast Cancer Res Treat
; 164(3): 649-658, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28508185
6.
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma.
Haematologica
; 100(5): 670-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25710456
7.
A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma.
Cancer Invest
; 29(7): 451-5, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21696296
8.
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).
Target Oncol
; 11(5): 643-653, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27154357
9.
Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
Leuk Lymphoma
; 44(2): 241-9, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12688340
10.
Pazopanib as second-line treatment after sunitinib or bevacizumab in patients with advanced renal cell carcinoma: a Sarah Cannon Oncology Research Consortium Phase II Trial.
Clin Genitourin Cancer
; 11(3): 270-5, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23665131
11.
High-dose bevacizumab in the treatment of patients with advanced clear cell renal carcinoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Clin Genitourin Cancer
; 11(3): 283-289.e1, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23684421
12.
Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma: a phase II trial of the Sarah Cannon Research Institute Oncology Research Consortium.
Melanoma Res
; 23(6): 468-73, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23969699
13.
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens.
Clin Cancer Res
; 19(14): 3987-95, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23743569
14.
A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma.
Leuk Lymphoma
; 57(1): 216-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25956042
15.
A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancer.
Clin Lung Cancer
; 12(3): 187-91, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21663862